Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death (PregnAnZI-2)
Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis and Death: a Phase III Double-blind Randomized Clinical Trial
Sponsor: London School of Hygiene and Tropical Medicine
Listed as NCT03199547, this PHASE3 trial focuses on Neonatal SEPSIS and remains completed. Sponsored by London School of Hygiene and Tropical Medicine, it has been updated 13 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE3
-
Oct 2021 — Apr 2022 [monthly]
Completed PHASE3
Status: Recruiting → Completed
▶ Show 8 earlier versions
-
Feb 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE3
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Dec 2018 — Mar 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Dec 2018 [monthly]
Recruiting PHASE3
-
Apr 2018 — Jun 2018 [monthly]
Recruiting PHASE3
-
Dec 2017 — Apr 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Dec 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- London School of Hygiene and Tropical Medicine
For direct contact, visit the study record on ClinicalTrials.gov .